Immunovaccine to Present New Pre-clinical Combination Therapy Data at the AACR Annual Meeting
March 24, 2017 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - March 24, 2017) - Immunovaccine Inc. (TSX:IMV)(OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that new pre-clinical data on...
Immunovaccine's Lead Immuno-Oncology Candidate to Enter Investigator-Sponsored Phase 2 Clinical Trial in Ovarian Cancer in Combination With Approved Anti-PD-1 Drug
February 06, 2017 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Feb. 6, 2017) - Immunovaccine Inc. (TSX:IMV)(OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that the UHN's Princess...
Immunovaccine Appoints Seasoned Financial Executive Pierre Labbe as CFO
February 03, 2017 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Feb. 3, 2017) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Immunovaccine to Present at 2017 BIO CEO & Investor Conference
February 02, 2017 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Feb. 2, 2017) - Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will...
Immunovaccine to Present at 2017 Biotech Showcase Conference
January 04, 2017 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Jan. 4, 2017) - Immunovaccine Inc. (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will...
Immunovaccine Announces Closing of $8 Million Bought Deal Private Placement Financing
December 09, 2016 09:23 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Dec. 9, 2016) -
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES
Immunovaccine Inc....
Immunovaccine Inc. ("IMV-T") - $8 Million Bought Deal Private Placement Financing
November 23, 2016 17:09 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 23, 2016) -
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF...
The European Medicines Agency Grants Orphan Drug Designation Status to Immunovaccine's DPX-Survivac in Ovarian Cancer
November 22, 2016 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 22, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Immunovaccine to Present at 2016 Biotech & Money Showcase Conference
November 14, 2016 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 14, 2016) - Immunovaccine Inc. (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will...
Immunovaccine Announces Third Quarter 2016 Financial Results and Provides Corporate Update
November 08, 2016 17:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 8, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical-stage vaccine and immunotherapy company,...